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1. Introduction 
Epilepsy is a condition with seizures by abnormal, recurrent, and excessive discharges from 
neurons. Observations in experimental models of epilepsy are providing a better 
understanding of the mechanisms of seizure-induced excitotoxicity, neuroprotective 
responses and neurogenesis (Naegele, 2007). Excitotoxic neurodegeneration can be 
investigated in epilepsy models employing kainic acid or pilocarpine. Each model results in 
distinctive patterns of degeneration within the hippocampus through kainate subclass of 
glutamate receptors or cholinergic receptors, respectively. Kainic acid triggers neuronal 
injury directly by binding to kainate receptors on mossy fiber endings and on the principal 
neurons of the hippocampus. Pilocarpine causes cell death of a majority of the nonprincipal 
neurons of the hilus and CA1 pyramidal cells.  
Intensive researches have shown that some steroids display neuroprotective properties in 
various diseases including epilepsy (Wojtal et al., 2006; Biagini et al., 2010). The steroids can 
be classified into ‘neuroactive steroids’ and ‘neurosteroids’. The term ‘neuroactive steroids’ 
may be synthesized both in the nervous system and in the endocrine glands such as gonads, 
adrenal glands and placenta, and exert their effects on neural tissue. ‘Neurosteroids’, the 
concept derived from Baulieu (1997), are a family of steroid hormones including 
pregnenolone, dehydroepiandrosterone, progesterone and their derivatives. Neurosteroids 
are synthesized in the nervous system de novo from cholesterol and accumulated in the 
nervous system independently of classical steroidogenic gland secretion rates.  
Neurosteroids act in the nervous system in an autocrine/paracrine configuration (Plassart-
Schiees & Baulieu, 2001). They may regulate gene expression by binding to nuclear receptors 
or affect neurotransmission through action at membrane ion-gated and other neurotransmitter 
receptors. In addition, they affect neuronal growth, survival and differentiation, cause 
regression of neuritic extensions before they have established contact with other neurons or 
glia and protect neurons from death. Modulatory roles of neurosteroids include Ǆ-amino-
butyric acid (GABA), N-methyl-D-aspartate, nicotinic/muscarinic cholinergic, serotonin, 
kainite and glycine receptor functions. 
Neuroprotective properties of neurosteroids have been revealed and gained particular 
attention in the treatment of diseases where neurodegeneration is predominant, including 
epilepsy (Naegele, 2007; Biagini et al., 2010). Seizures not only cause cell death, but also elicit 
neuroprotective responses in injured neurons and glia. Seizures trigger the release of 
neuroactive steroids that impair hippocampal neuron survival in excitotoxicity. Increased 
neurosteroid synthesis, presumably occurring in glial cells during epileptogenesis, delays 
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the appearance of recurrent spontaneous seizures in temporal lobe epilepsy. In this chapter, 
various molecules connected with neurosteroidogenesis are reviewed in order to provide 
further understanding on epilepsy.  
2. Neurosteroids and lipid/cholesterol 
Lipids have broad information carrying function in the central nervous system (CNS) as 
both ligands and substrates for proteins (Adibhatla & Hatcher, 2008). Lipid metabolism may 
be important for the CNS, as this organ has the highest concentration of lipids next to 
adipose tissue. The crucial role of lipids in tissue physiology and cell signaling is 
demonstrated by the many neurological disorders, and altered lipid metabolism is also 
believed to be a key event which contributes to CNS injuries. Lipids serve not only 
structural components of the cell membrane but also precursors for various second 
messengers. Especially, cholesterol is an important regulator of lipid organization and the 
precursor for steroid biosynthesis. 
The first step in the biosynthesis of neurosteroids is the conversion of cholesterol to 
pregnenolone (Wojtal et al., 2006; Biagini et al., 2010). This reaction is catalyzed by the 
cytochrome P450 cholesterol side-chain cleavage (p450scc) in successive chemical reactions. 
First and foremost, transport of cholesterol to the mitochondria is a prerequisite for 
neurosteroidogenesis. Cholesterol is not only needed for the growth and remodeling of 
neuronal and glial membranes, but also is an important regulator of lipid organization and the 
precursor for steroid biosynthesis (Adibhatla & Hatcher, 2008). The majority of cholesterol in 
the brain is derived from de novo synthesis in the neurons, astrocytes predominantly, and 
oligodendrocytes. Cholesterol is then secreted via transport molecules, taken up by lipoprotein 
receptors on neurons and internalized to the endosome/lysosome system. 
Cholesterol is transported to mitochondria by Niemann-Pick C1 (NPC1) protein where the 
neurosteroids are synthesized via the rate limiting intermediate, pregnenolone (Adibhatla & 
Hatcher, 2008). NPC1 protein is involved in transport of lipids, particularly cholesterol, from 
the late endosome/lysosome. Deficiency in the protein results in lysosomal accumulation of 
cholesterol and other lipids. Then, proteins located in the mitochondrial membranes, such as 
peripheral benzodiazepine receptor (PBR) and steroidogenic acute regulatory protein 
(StAR), allow cholesterol to cross the hydrophilic intermembrane space (Lavaque et al., 
2006). In the mitochondria, the neurosteroids are synthesized from the cholesterol via the 
rate limiting intermediate pregnenolone.  
Observations are providing a better understanding of the transport of cholesterol by NPC1, 
PBR or StAR (Adibhatla & Hatcher, 2008). Niemann-Pick disease type C is due to mutations 
in either the NPC1 or NPC2 genes, resulting in defective cholesterol transport and 
cholesterol accumulation. The PBR, which might function as a cholesterol channel, is 
essential for the delivery of cholesterol to the inner mitochondrial membrane and the 
synthesis of steroids. However, it should be noted that these molecules are not the only 
molecules implicated in the metabolism of cholesterol and little attention has been paid to 
StAR-related lipid transfer (START) domain-containing proteins (START proteins).  
3. START proteins 
START domain is an evolutionary conserved protein module of approximately 210 amino 
acids (Soccio & Breslow, 2003; Alpy & Tomasetto, 2005; Lavigne et al., 2010). START domain 
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is conserved through in plants and animals and serves as a versatile binding interface for 
lipids. The crystal structures of solved START domain reveal a conserved ‘helix-grip’ fold, 
in which a central antiparallel ǃ-sheet is gripped by N-terminal and C-terminal ǂ-helices, the 
latter being closely packed above the nine-strand curved ǃ-sheet.  
In humans, START domains are found in 15 distinct proteins and can be classified by 6 
subfamilies (Table 1). Mammalian START proteins have diverse expression patterns and can 
be found free in the cytoplasm, attached to membranes or in the nucleus. START proteins 
implicate in intracellular lipid transport, lipid metabolism, and cell signaling events. 
Mutation or mis-expression of START proteins is linked to pathological processes, including 
genetic disorders, autoimmune diseases and cancer. Nevertheless, START proteins have not 
been extensively studied in the nervous system except 2 proteins, StAR and StarD6. 
 
Group Other names Subcellular localization Gene 
StarD1 StarD1/StAR 
StarD3/MLN64 
Mitochondria 
Late endosomes 
8p11.2 
17q11-q12 
StarD4 StarD4 
StarD5 
StarD6 
Cytosol and Nucleus 
Cytosol and Nucleus 
Nucleus 
5q22.1 
15q26 
18q21.2 
StarD2 StarD2/PCTP 
StarD7 
StarD10 
StarD11/CERT 
Cytosol 
? 
Cytosol and Nucleus 
Cytosol and Golgi 
17q21-q24 
2q11.2 
11q13 
5q13.3 
RhoGAP StarD8 
StarD12/DLC-1 
StarD13/DLC-2 
? 
Plasma membrane 
Cytosol 
Xq13.1 
8p22 
13q12-q13 
Thioesterase StarD14/BFIT 
StarD15/CACH 
? 
Cytosol 
1p32.3 
5q14.1 
StarD9 StarD9 ? 15q15.1-q15.2 
Table 1. Phylogenetic group and 15 human START proteins quoted from Alpy & Tomasetto 
(2005) with slight modification. BFIT, brown fat-inducible thioesterase; CACH, cytoplasmic 
acetyl-CoA hydrolase; CERT, Goodpasture-antigen-binding protein ∆ 26; DLC, deleted in 
liver cancer; MLN64, metastatic lymph node 64; PCTP, phosphatidylchoine transfer protein; 
RhoGAP; Rho-GTPase-activating-protein-domain.  
3.1 Subcellular characteristics of StAR and StarD6 
StAR, the prototype of START proteins, is first characterized in murine MA-10 Leydig 
tumor cells that luteinizing hormone induces the expression of StAR and ultimately results 
in increased synthesis of pregnenolone (Clark et al., 1994). Its function has been extensively 
studied in classical steroidogenic tissue such as adrenal gland and ovary, and it has been 
shown to be involved in the intramitochondrial trafficking of cholesterol (Stocco, 2001). In 
steroidogenic cells, StAR-mediated delivery of cholesterol to inner mitochondrial membrane 
is a hormonally regulated step and StAR expression is tightly regulated (Stocco, 2001; Stocco 
et al., 2005).  
StarD6 is originally reported in male germ cell–specific protein of StarD4 group of START 
proteins (Soccio et al., 2002; Gomes et al., 2005). It is immunolocalized only in the nuclei of 
germ cells, not in the interstitial cells of Leydig, and may have a pivotal role in 
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spermatogenesis rather than in steroidogenesis. StarD6 is detected in the nucleus of mature 
sperm cells, where it could interact with transcriptional machinery in a lipid-dependent 
manner. Since lipids play an important role in sperm capacitation and function, StarD6 might 
regulate lipid movement within the sperm cell membrane.  
StarD6 in the Leydig cells has also been reported under perinatal hypothyroidism while 
germ cell-specific immunoreactivity is delayed (Chang et al., 2007a), which means that 
StarD6 also might play a role in the steroidogenesis under certain conditions such as 
testosterone deficiency. In this context, StarD6 might interact with mitochondrial membranes 
just similar to that of StAR (Bose et al., 2008). StarD6 has a protease-sensitive C-terminus 
similar to that of StAR and exhibits a steroidogenic activity equal to StAR. Recently, this 
question is ascertained in the nervous system by morphometry (Chang et al., 2010). 
 
 
Fig. 1. Micrographs of StAR and StarD6 in cultured dopaminergic neurons (SK-N-SH cell 
line). StAR is localized in the cytoplasm (arrows) but StarD6 loses the localization in nucleus 
(open arrow) according to maturation. Original magnification X40. (quoted from Chang et 
al., 2010)  
Morphological aspects of StarD6 are significantly different from those of StAR in cultured 
neuronal and glial cells. Cultured cells are dopaminergic neuronal cells (SK-N-SH) and glioma 
cells, M059-K and M059-J, which M059-J lack DNA-dependent protein kinase (DNA-PK) 
activity while M059-J express normal levels of DNA-PK. StAR tends to localize in the 
cytoplasm but StarD6 showed a weak intensity in the nucleus according to neuronal 
maturation (Fig. 1), while both are immunolocalized in the nuclei as well as the cytoplasm in 
glioma cells. The number of StAR and StarD6 immunopositive cells is significantly different in 
SK-N-SH and M059-K and M059-J, respectively. Especially, the immunoreactivities of StarD6 
in glioma cells are considerably changed by the presence of DNA-PK, while there is no 
significance in StAR (Fig. 2). 
The morphometric results with StarD6 in glioma cells have meaning, since oxidative DNA 
damage by excitotoxicity may activate DNA repair proteins in affected neurons (Naegele, 
2007). The number of StarD6 is significantly decreased in the glioma cell line which lacks 
DNA-PK activity. DNA-PK plays a role in nonhomologous end joining (NHEJ) against DNA 
damage, which comprises of catalytic subunit of the DNA-PK (DNA-PKcs), Ku70, and Ku80 
(Martin, 2008). NHEJ system is activated by severe forms of DNA damage, DNA double-
stand breaks. Increasing evidences implicate DNA-PK in neuroprotective properties. 
Experimental DNA-PK null mice show increased excitotoxicity and result in augmented 
StAR StarD6 
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apoptosis (Culmsee et al., 2001; Neema et al., 2005). It suggests that the activity of StarD6 in 
the nucleus might depend on the DNA repair system in preventing DNA damage.  
 
 
Fig. 2. Histographs of StAR and StarD6 in cultured glioma cell lines. M059-J cells lack DNA-
dependent protein kinase (DNA-PK) activity, while M059-K cells express normal levels of 
DNA-PK (acquired from American Type Culture Collection, ATCC, Rockville, MD, USA). 
The number of immunopositive cells was significantly different by StAR or StarD6 in the 
M059-K and M059-J, respectively (*p<0.05). Unlike StAR, the immunoreactivities of StarD6 
were considerably changed by the presence of DNA-PK (§p<0.05), and it was also 
demonstrated by Western blot analysis. Data are quoted from Chang et al., 2010 (left) and 
unpublished data (right). 
3.2 Distribution of StAR and StarD6 in the nervous system 
StAR appears to be widely distributed throughout the brain, although different levels of 
expression have been detected between different brain areas including human (Furukawa et 
al., 1998; King et al., 2002; Sierra et al., 2003; Sierra, 2004; Lavaque et al., 2006). High levels of 
StAR mRNA expression have been detected in the cerebral cortex, hippocampus proper, 
dentate gyrus, olfactory bulb, and cerebellar cortex. In general, there is a good agreement 
between those from in situ mRNA localization and data from immunohistochemical studies. 
This may implicate that steroidogenesis is a generalized process in the nervous system.  
StAR immunoreactivity has been detected in several neuronal populations, in ependymocytes 
and in some astrogial cells in the brain (Lavaque et al., 2006). StAR expression, however, seems 
to be restricted to very specific neuronal and astroglial populations in each brain area. Strong 
StAR immunoreactivity is observed in the soma of large neurons, which are characterized by 
high mitochondrial content. Although StAR is predominantly expressed by neurons in the 
CNS, astrocytes also express STAR and is known to synthesize neurosteroids from cholesterol.  
StAR may contribute to the regulation of cell proliferation in the nervous system, since steroids 
are known to affect neuronal and glial differentiation (Lavaque et al., 2006). Important changes 
in the pattern and/or level of expression of StAR occur in different brain areas during 
postnatal development (Kim et al., 2002; Sierra et al., 2003). For instance, in the cerebellar 
cortex Purkinje cells express StAR as well as have an active steroidogenic activity, in particular 
during the developmental period (Tsutsui et al., 2003). Changes of StAR in the developing 
cerebellar cortex may therefore be related with the differentiation of Purkinje cells. Important 
changes in the expression of StAR occur as well during brain aging. In 24-month-old rats StAR 
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immunoreactivity is increased in hippocampal and cortical neurons compared with young 
animals (Sierra et al., 2003), while decreased in the aged cerebellum (Lavaque et al., 2006). It is 
unknown what is the physiological significance of these changes in StAR expression in the 
brain and whether they are associated with differences in steroidogenesis. 
Furthermore, StAR is colocalized in the same neural cells with p450scc and with other 
steroidogenic enzymes (Furukawa et al., 1998; King et al., 2002). It may implicate that StAR 
as a transport protein may participate in neurosteroidogenesis in the CNS. Strikingly, no 
deficiency in brain function or structure was reported either in StAR knockout mice or in 
congenital adrenal hyperplasia patients (Sierra, 2004). The brain may have StAR-
independent mechanisms of mitochondrial cholesterol transport. It should be noted that 
other proteins that contain the START domain might be involved in steroidogenesis and 
that their regional patterns of expression in the brain remain to be determined.  
 
 StAR StarD6 
Cerebrum Neuron (layers V-VI) >>glia Neuron (layers V-VI) >glia 
Hippocampus 
   Cornu ammonis 
   Dentate gyrus 
 
Strata oriens/radiatum 
Mild granular layer 
 
Stratum pyramidale 
Granular layer 
Cerebellum Purkinje cell (+) Purkinje cell (±) 
Table 2. Distribution of StAR and StarD6 in the nervous system. Although StAR and StarD6 
can be detected in neurons and glia, they are primarily immunolocalized in the neurons of 
rodents. Unlike the cerebral cortex, they have compensatory distribution in the 
hippocampus and cerebellum. (According to Furukawa et al., 1998; King et al., 2002; Sierra 
et al., 2003; Sierra, 2004; Chang et al., 2007b, 2009, 2010) 
Not much is known on the distribution, development and aging of StarD6 in the CNS  
(Table 2). StarD6 is seen in the cerebral cortex, cerebellum, hippocampus, spinal cord and 
dorsal root ganglia (Chang et al., 2007b, 2009), where the highest expression of StAR is 
reported (Sierra, 2004; Lavaque et al., 2006). Strong StarD6 immunoreactivity is observed in 
deeper layers of cerebral cortex, principal cell layers of hippocampus and substantia gelatinosa 
of spinal cord, but devoid in Purkinje cell layer of cerebellum and lower motor neurons of 
spinal cord. From morphological point of view StarD6 also immunolocalized in glial cells, but 
the characteristics are not determined properly.  
StarD6 immunolocalization was mainly restricted to the nucleus, but cytoplasmic 
immunostaining frequently appeared in the principal neurons of hippocampus and spinal 
cord. This subcellular localization pattern is a distinctive feature of StarD4 group (Alpy & 
Tomasetto, 2005; Soccio et al., 2005). But the characteristics of the immunostaining of the 
StarD6 in the cytoplasm and the nucleus remain largely undetermined. The existing data 
(Gomes et al., 2005; Chang et al., 2007a,2007b,2009,2010; unpublished data) are obtained 
with the rat-specific polyclonal anti-StarD6 antibody (raised from Dr. Soh’s laboratory, 
Chonnam National University, Republic of Korea), and it should be confirmed by the 
monoclonal antibody. 
3.3 Changes of StAR and StarD6 in epilepsy 
3.3.1 Generalized changes of StAR and StarD6 in epileptic hippocampus 
Neurosteroids can interact with various neurotransmitters (Joëls, 2009; Biagini et al., 2010). 
In particular, neurosteroids are well known to potentiate the actions of GABA via GABAA 
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receptors against stress. Neurosteroids not only facilitate inhibitory responses, but also 
reduce the slope of the field excitatory postsynaptic potential in the dentate gyrus toward 
more inhibition. Various neurotrophic factors, including hormones, alter cellular activity in 
all hippocampal subfields in a region-specific way (Joëls, 2009).  
StAR has been related to neuroprotection (Sierra et al., 2003; Sierra, 2004). StAR mRNA and 
protein levels are transitorily increased following excitotoxic brain injury induced by the 
administration of kainic acid (Sierra et al., 2003). A fast and transient increase in StAR 
mRNA levels in the hippocampus was detected in the first 12 hours after injury. This was 
accompanied by an increase in StAR immunoreactivity in granular and hilar hippocampal 
neurons in the first 12-24 hours after the administration of kainic acid. 
In addition, StAR immunostaining is more intense in neurons located in the strata oriens 
and radiatum of normal hippocampus. The pattern of distribution changed in the 
pilocarpine-induced epileptic hippocampus (Chang et al., 2010). StAR was immunolocalized 
in the stratum pyramidale as well as the strata oriens and radiatum 3 hours after pilocarpine 
treatment, while changed immunoreactivity in the dentate gyrus was not remarkable. But, 
the changes in distribution in the hippocampus proper did not discussed in kainic acid-
induced epilepsy model (Sierra et al., 2003).  
A strong increase in StAR immunoreactivity was observed in layers II and III of the 
pyriform cortex of kainic acid-injected animals (Sierra et al., 2003). However, in deeper 
cortical layers the cellular mortality was very high. Therefore, a large increment of StAR 
expression of hippocampal granular neurons after brain injury is especially resistant to the 
toxicity of kainic acid. The expression in dentate gyrus is related to neuroprotection in status 
epilepticus. Moreover, subgranular neurons have mitotic activity and increased StAR might 
affect on neurogenesis and differentiation in epileptic hippocampus. 
StarD6 is acutely and transiently increased after excitotoxic brain injury also (Chang et al., 
2009, 2010). The changes are seen in the granular and polymorphic layers of the dentate gyrus 
and the CA subfields of the hippocampus 3 hours after pilocarpine treatment. In the CA1-2 
areas, StarD6 immunoreactivity was increased in the strata lacunosum-moleculare as well as 
stratum oriens and stratum radiatum after the lesion. This increase in immunolocalization 
remained until 12 hours after experiencing epilepsy, and then slightly decreased up to  
24 hours after epilepsy. StarD6 immunoreactivity remained in the pyramidal layer of the  
CA subfields, whereas the granular layer of dentate gyrus was not very intensely stained.  
In agreement with the distributional changes, a significant increase in StarD6 protein is 
detected 3 hour after brain injury with respect to the untreated animals and 24 hours after 
epilepsy.  
Similar results in distribution and Western blot analysis are obtained in domoic acid-induced 
epilepsy model (unpublished data). Domoic acid is a kainic acid analogue and 
characteristically damages the hippocampus since hippocampus has well developed 
glutamate receptors (Coulter et al., 2002; Naegele 2007). Western analysis revealed significant 
change in the level of StarD6 in response to domoic acid, an increase being observed 4 hours 
after the epilepsy compared with normal hippocampus.  
3.3.2 Time-course of StAR and StarD6 after epileptic injury 
Neurosteroids are potent trophic and survival factors for the nervous system and the 
synthesis is related to the extent of p450scc induction. The p450scc enzyme is found in 
neurons, astrocytes, oligodendrocytes, and in activated microglial cells (Biagini et al., 2010).  
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Fig. 3. Compensatory distribution of StAR and StarD6 in normal and epileptic 
hippocampus. StAR immunolocalization was seen in the strata oriens and radiatum while 
StarD6 in the stratum pyramidale in normal hippocampus. Augmented immunolocalization 
of StAR was observed in the stratum pyramidale and StarD6 in the strata lacunosum-
moleculare after pilocarpine-induced epilepsy. Figures are aligned by stratum pyramidale. 
Original magnification X20.  
Neurosteroid levels can be altered as consequence of neuronal damage as well as of glial cell 
activation. A significant increase in p450scc both in neurons and glial cells is reported, but 
the neuron-specific changes were limited to the first few days after status epilepticus 
whereas those in glial cells were long-lasting. Therefore, neurosteroidogenesis is related to 
the extent of p450scc induction in glial cells consequent to status epilepticus.  
Activation of various molecules connected with steroidogenesis after brain injury results in 
a significantly increased synthesis of neurosteroids. Interestingly the increase in StAR and 
StarD6 was restricted to neurons in epileptic hippocampus. An urgent increase of StarD6, 
even compared with StAR, after excitotoxic brain injury may be the first attempt to respond 
to primary neurodegeneration (Figure 4). Early induction of StarD6 as well as StAR is 
followed by later increase in the expression of various steroidogenic enzymes including 
p450scc (Furukawa et al., 1998; Garcia-Ovejero et al., 2002; Biagini et al., 2006). 
The induction of StAR in neurons under neurodegenerative conditions is followed by the 
increase in the expression of PBR in glial cells (Lavaque et al., 2006). The induction of 
StAR and PBR has a different time course. StAR expression is increased within the first 
Normal Epilepsy StAR 
StarD6 
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day after lesion while the increase in PBR expression is observed from 1 to 5 weeks after 
lesion. Therefore, StAR and PBR may participate in different phases of steroidogenesis 
after brain injury. The increased expression of these molecules may be the cause of the 
increase in the production of neurosteroids, such as pregnenolone. Changes in the 
expression of StAR and PBR may also result in the production of other neuroprotective 
steroids.  
Meanwhile, the results with StarD6 suggest another aspect on neurosteroidogenesis. On  
the assumption that StarD6 participate in the regulation of the production of 
neuroprotective steroids, the responses of StarD6 might be coincided with the hypothesis 
that it is the first attempt to respond to epilepsy in accordance with brain injury resulting in 
a significant increased synthesis of neurosteroids (Di Michele et al., 2000). As a result, 
nuclear immunostaining and early response of StarD6 may regulate gene expression by 
binding to nuclear receptors (Mellon et al., 2001; Plassart-Schiess & Baulieu, 2001). StarD6 
can act as transcriptional machinery in a lipid-dependent manner and thus stimulate 
neurosteroidogenesis by activating StAR and other steroidogenic enzymes. But, direct 
relationship between StAR and StarD6 is not confirmed yet in the nervous system.  
 
 
Fig. 4. Representative changes in StAR and StarD6 in the hippocampus after excitotoxic 
insult. The histogram shows relative densitometric values of StAR mRNA (Sierra et al., 
2003) and StarD6 protein (Chang et al., 2009; unpublished data). The animals killed 12 h 
after kainic acid (KA) administration showed a significant increase in StAR mRNA levels. 
Considerable changes in StarD6 level in response to domoic acid (DA) or pilocarpine (Pilo) 
observed 3-4 hours after the epilepsy. (The densitometric results are modified from original 
manuscript)  
3.3.3 Area-specific changes of StAR and StarD6 in epileptic hippocampus 
Epilepsy could cause widespread neurodegeneration in CA1-3 pyramidal layers of the 
hippocampus (Naegele, 2007), but there is enough ground for controversy on the area-
specific degeneration of hippocampus. Epilepsy-related neurodegeneration is mainly 
limited to CA3 area of the hippocampus (Neema et al., 2005; Kajitani et al., 2006; Ma et al., 
2006; Chuang et al., 2009; Zhang et al., 2009), while the neurons in CA1 area survive in 
0
0.5
1
1.5
2
0 3 6 12 24
KA-StAR
DA-StarD6
Pilo-StarD6
# 
*
(hours)
*
www.intechopen.com
 Underlying Mechanisms of Epilepsy 
 
54
various animal models (Marti et al., 2002; Dinocourt et al., 2003; Cavazos et al., 2004; Sanon 
et al., 2005; Wittner et al., 2005). 
When rats are treated with kainic acid, a rapid and transient increase in StAR mRNA and 
protein was detected 12 hours after brain injury in the hippocampus (Sierra et al., 2003). A 
strong increase in StAR immunostaining was observed in the granular layer of dentate gyrus 
while the control hippocampus was not very intensely stained. The results do not provide 
effective involvement of StAR for steroidogenesis, but possible role in neuroprotection in 
neurons against excitotoxic injury. In this context, distribution of StAR changed in the 
pilocarpine-induced epileptic hippocampus (Chang et al., 2010). StAR immunostaining is 
localized in the strata oriens and radiatum of normal hippocampus, and in the stratum 
pyramidale as well in epileptic hippocampus. The changes in immunolocalization are reported 
in CA1-2 areas, not in the dentate gyrus.  
Similar results on area-specific changes are reported with StarD6 in epileptic hippocampus 
(Chang et al., 2009, 2010; unpublished data). The StarD6 immunolocalizations are seen in the 
strata lacunosum-moleculare as well as strata oriens and radiatum after excitotoxic injury 
with pilocarpine and domoic acid, respectively. The changes in the strata correspond with 
distribution of steroidogenic enzymes such as p450scc (Furukawa et al., 1998; Garcia-
Ovejero et al., 2002; Biagini et al., 2006). As a result, StarD6, StAR and p450scc might act in 
consecutive order following excitotoxic brain injury, result in neurosteroidogenesis. 
In addition, the morphometric data (Chang et al., 2010) with StarD6 in DNA-PK deficient 
cells are in accord with the previous reports that lack of DNA-PK promotes apoptosis 
(Culmsee et al., 2001; Neema et al., 2005). It can be interpreted that the activity of StarD6 in 
the nucleus might depend on the DNA repair proteins. To investigate whether StarD6 is 
related with DNA repair system in nervous system, epilepsy model was established by 
domoic acid (unpublished data, Fig. 5). Contrary to the hypothesis based on previous 
reports, there was negative correlation between StarD6 and NHEJ (data not shown).  
But the levels of apurinic/apyrimidinic endonuclease (APE, also called redox factor-1) and 
8-oxoguanine DNA glycosylase (Ogg1) increased considerably at 4 hours after domoic acid 
injection. The responses are quite similar to previous reports with kainic acid (Quach et al., 
2005; Jarrett et al., 2008) and that of StarD6 (Fig. 4). The results support the notion that 
oxidative DNA damage in neurons is primarily removed by base excision repair (BER) 
pathway rather than by NHEJ (Fishel et al., 2007). Despite activation of DNA repair systems 
after excitotoxic injury, the repair responses may not sufficient to overcome for extensive 
DNA damage.  
The distribution of BER proteins revealed that transient increase of APE in strata radiatum 
and lacunosum-moleculare and Ogg1 in stratum pyramidale. Increased immunoreactivities 
of APE and Ogg1 diminished in the pyramidal cells of CA3 area 24 hours after domoic acid 
injection compared to CA1. In case of StarD6, the immunostaining was induced in the strata 
radiatum and lacunosum-moleculare after epilepsy and then normalized in the stratum 
pyramidale in CA3 as well as CA1. Neurodegeneration in CA3 pyramidal cells may be 
caused by the decreased BER activity after seizure since there was no area-specific change in 
StarD6 especially in CA3. StarD6 in the nucleus did not respond on DNA repair system after 
epilepsy, but immunolocalization of StarD6 as well as APE in the strata lacunosum-
moleculare may have significance where localized various steroidogenic enzymes 
(Furukawa et al., 1998; Patte-Mensah et al., 2003; Biagini et al., 2006; Wojtal et al., 2006; Chia 
et al., 2008).  
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Fig. 5. Area-specific changes of StarD6 and APE in epileptic hippocampus. 
Immunoreactivities of StarD6 and APE increased in the strata radiatum and lacunosum-
moleculare (*) 3 hours after epilepsy (C and D) compared with control hippocampus (A and 
B) or 5 days after epilepsy (E and F). Note the changes in stratum pyramidale. Although 
StarD6 immunoreactivity remained in all subfields, the intensities diminished in CA3 
(arrow) while those in CA1 were maintained. Scale bar = 1mm. 
3.3.4 Functional aspects of StAR and StarD6 in epileptic hippocampus 
StAR has been shown to be involved in the intramitochondrial trafficking of cholesterol 
(Alpy & Tomasetto, 2005; Lavigne et al., 2010). Then, cholesterol is made available to the 
first enzyme of the steroidogenic pathway, p450scc, which transforms cholesterol into 
pregnenolone, the precursor for glucocorticoids, mineralocorticoids and sex steroids. StAR-
mediated delivery of cholesterol to the inner mitochondrial membrane, where p450scc is 
located, is a hormonally regulated step, which is rate limiting in steroidogenesis.  
The up-regulation of StAR expression after excitotoxic injury suggests that this protein may 
play a role in the adaptation of neural tissue to neurodegenerative conditions (Sierra et al., 
2003; Sierra, 2004; Lavaque et al., 2006; Chang et al., 2010). That is, StAR in the dentate gyrus 
and hippocampus might be associated with neuroprotection and neurosteroidogenesis, 
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respectively. Strikingly, no deficiency in brain function or structure was reported either in 
StAR knockout mice or in congenital adrenal hyperplasia patients (Sierra, 2004). The brain 
may have StAR-independent mechanisms of mitochondrial cholesterol transport.  
It should be noted that StAR is not the only molecule implicated in the mitochondrial 
transport of cholesterol. PBR, which might function as a cholesterol channel, is essential for 
the delivery of cholesterol to the inner mitochondrial membrane and the synthesis of 
steroids. NPC1 is also involved in transport of lipids from the late endosome to 
mitochondria. Furthermore, there has been described a family of proteins which contain the 
START domain. These START domain proteins, such as StarD6, are related to 
steroidogenesis.  
In some START proteins, the START domain probably functions in lipid sensing rather than 
in lipid transfer (Alpy and Tomasetto, 2005; Lavigne et al., 2010). StarD2/PCTP, StarD4, 
StarD5 and StarD10 are detected in the cytoplasm and nucleus, and StarD6 only in the 
nucleus. It is therefore possible that some START-containing proteins have nuclear roles and 
may even regulate transcription in a lipid-dependent manner. Structurally, the START 
domain contains a lipid-binding domain specific for diacylglycerol/phorbol-ester, the C1 
domain (Brose and Rosenmund, 2002) and functions as a lipid-sensing domain providing a 
rapid way of regulating the catalytic activity, and thus modulates lipid metabolism.  
 
 
Fig. 6. Schematic representation of various molecules participating in neurosteroidogenesis. 
StAR and PBR is mainly localized in the outer mitochondrial membrane of neuron and glia, 
respectively, while p450scc acts in the inner mitochondrial membrane. Note StarD6 in the 
nucleus, which may interact with StAR for neurosteroidogenesis. Stimulus-dependent up-
regulation of START proteins appears as follows; StarD6 in a few hours and StAR in a day, 
while PBR and p450scc in a few weeks.  
The changed immunolocalization of StarD6 in the strata lacunosum-moleculare might 
suggest a role of this protein as a regulator of transcription related to the cholesterol 
metabolism (Chang et al., 2009, 2010, unpublished data). Although StAR is a well known 
protein implicated in the steroidogenesis, StarD6 changed the localization from stratum 
pyramidale to the strata lacunosum-moleculare after excitotoxic injury. Another important 
change is the time course of responsiveness after epilepsy. The response of StarD6 arises 
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from the nucleus with DNA repair proteins to respond to excitotoxic stimuli. StarD6 can 
function as a lipid-sensing domain and modulate neurosteroid synthesis.  
There is growing evidence that cholesterol is of particular importance in development of 
Alzheimer’s disease (Wojtal et al., 2006; Adibhatla & Hatcher, 2008). In the patients’ brains 
of Alzheimer’s disease, a general trend was observed towards decreased levels of all 
steroids. The lower levels correlated with increased amounts of ǃ-amyloid peptides and 
phosphorylated tau proteins. Increased level of StAR is reported in aged rats (Sierra et al., 
2003) and in patients with Alzheimer’s disease (Webber et al., 2006) compared with young 
animals and age-matched patients without dementia, respectively. It means that the 
expression of StAR hormonally regulated by the level of neurosteroids in the nervous 
system. Although the existing knowledge on StarD6 is still incomplete, it can be expected 
that StarD6 is also regulated by the levels of neurosteroids, cholesterol and lipid. 
Furthermore, StarD6 is localized in the nucleus and appears early response than StAR in 
epilepsy (Chang et al., 2009, 2010, unpublished data), results in stimulus-dependent 
expression of StAR follows after StarD6.  
4. Conclusion 
The START domain operates as a lipid exchange and/or a lipid-sensing domain. There are 
15 mammalian proteins that possess a START domain, an evolutionary conserved protein 
module and they are involved in several different biological processes: lipid transfer, lipid 
metabolism and signal transduction. While the role of StAR in steroid hormone production 
has been demonstrated, StarD6 remain largely uncharacterized. Much less is understood 
about how its START domain specifically recognizes cholesterol and how it affects on other 
molecules participating in neurosteroidogenesis. StarD6 can take precedence over other 
molecules such as StAR, PBR and p450scc in excitotoxic brain injury and they might be 
hormonally regulated. There are no reports on the brain function or structure in StarD6 
knockout animal model or in patients’ brain and the brain may have StarD6-independent 
mechanisms of lipid/cholesterol sensing. Therefore, further studies are needed to elucidate 
the exact nuclear roles of StarD6 on neurosteroidogenesis with StAR in the nervous system. 
It could suggest new therapeutic strategy for epilepsy since neurosteroids act as autocrine or 
paracrine neuromodulators and the regulation of neurosteroidogenesis may have profound 
influences in the nervous system. 
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